Biotech

All Articles

Lykos will certainly inquire FDA to reexamine its selection observing denial of MDMA treatment for post-traumatic stress disorder

.Adhering to an unsatisfactory revealing for Lykos Therapies' MDMA applicant for trauma at a latest ...

AN 2 halves roll call, stops period 3 test after records let down

.AN2 Rehabs is actually reconsidering its own organization in action to lackluster midphase records,...

Merck pays $700M for bispecific, snooping autoimmune opening and also chance to test Amgen in cancer

.Merck &amp Co. is actually spending $700 thousand upfront to test Amgen in a blood cancer market. T...

Gilead pays J&ampJ $320M to go out licensing deal for seladelpar

.With Gilead Sciences on the verge of an FDA decision for its liver disease medication seladelpar, t...

' All palms on deck' at Lilly as peers target weight problems market

.CEO David Ricks can easily find the business putting together tents at basecamp responsible for Eli...

Entero giving up staff, abandoning workplace and pausing R&ampD

.Bed mattress Liquidators has switched Entero Therapeutics white colored as a sheet. The collector b...

Exelixis goes down ADC after choosing it's no match for Tivdak

.Exelixis is actually surrendering on its tissue element (TF)- targeting antibody-drug conjugate aft...

Relay loses interest in SHP2 prevention after Genentech leaves

.3 full weeks after Roche's Genentech unit bowed out an SHP2 prevention deal, Relay Therapeutics has...

Stoke's Dravet disorder med released of predisposed professional grip

.Stoke Rehabs' Dravet syndrome drug has actually been without a partial grip, getting rid of the way...

Fierce Biotech's Gabrielle Masson shows Ferocious 15 at NYSE

.Fierce Biotech Partner Publisher Gabrielle Masson presented the 2024 course of Tough 15 winners on ...